News headlines about MISONIX (NASDAQ:MSON) have been trending somewhat positive on Saturday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. MISONIX earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 48.4003017751072 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Shares of MISONIX (MSON) traded up 0.542% on Friday, reaching $10.205. 5,310 shares of the company’s stock traded hands. The firm’s 50 day moving average is $10.01 and its 200 day moving average is $9.81. The firm’s market capitalization is $95.49 million. MISONIX has a 52 week low of $5.87 and a 52 week high of $12.00.
ILLEGAL ACTIVITY NOTICE: “MISONIX (NASDAQ:MSON) Earning Somewhat Favorable Media Coverage, Accern Reports” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/28/misonix-mson-earns-coverage-optimism-score-of-0-22.html.
MISONIX Company Profile
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for MISONIX Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MISONIX Inc. and related companies with MarketBeat.com's FREE daily email newsletter.